Calcium Requirements in Children According to ASPEN Guidelines
For children on parenteral nutrition, calcium requirements are age-stratified and range from 0.25-0.4 mmol/kg/day (10-16 mg/kg/day) for children aged 1-18 years, with higher requirements for infants and preterm neonates to ensure optimal growth and bone mineralization. 1
Age-Specific Parenteral Calcium Requirements
The ESPGHAN/ESPEN/ESPR/CSPEN guidelines (which align with international parenteral nutrition standards including ASPEN principles) provide the following calcium dosing for parenteral nutrition 1:
Preterm and Term Infants:
- Preterm infants (first days of life): 0.8-2.0 mmol/kg/day (32-80 mg/kg/day)
- Growing premature infants: 1.6-3.5 mmol/kg/day (64-140 mg/kg/day) - the highest requirement due to rapid bone mineralization needs
- 0-6 months (includes term newborns): 0.8-1.5 mmol/kg/day (30-60 mg/kg/day)
- 7-12 months: 0.5 mmol/kg/day (20 mg/kg/day)
Children and Adolescents:
- 1-18 years: 0.25-0.4 mmol/kg/day (10-16 mg/kg/day)
Critical Implementation Principles
Calcium must always be provided with simultaneous phosphorus supplementation to ensure proper bone mineralization, as calcium and phosphorus form microcrystalline apatite (the bone mineral) only when both are available in optimal proportions 1. The guidelines emphasize providing a "slight surplus" of both minerals to ensure optimal tissue and bone mineral accretion 1.
Key Monitoring Requirements:
Regular monitoring is mandatory and should include 1:
- Serum calcium, phosphorus, and magnesium concentrations
- Alkaline phosphatase levels
- Urine calcium and phosphorus concentrations
- For long-term PN: vitamin D status and bone mineral density assessment
Critical Pitfalls to Avoid:
Precipitation Risk: Use organic calcium and phosphate salts (such as calcium gluconate and glycerophosphate) rather than inorganic salts to prevent dangerous calcium-phosphate precipitation in PN solutions 1
Aluminum Contamination: Avoid acidic calcium gluconate solutions packaged in glass vials as they are contaminated with aluminum and should not be used in PN 1
Hypophosphatemia in Early PN: In preterm infants during the first days of life, use a molar Ca:P ratio below 1 (0.8-1.0) when calcium and phosphorus intakes are at the lower range to prevent early postnatal hypercalcemia and life-threatening hypophosphatemia 1
Refeeding Syndrome: In growth-restricted preterm infants or malnourished children, monitor plasma phosphate closely as severe hypophosphatemia can result in muscle weakness, respiratory failure, cardiac dysfunction, and death 1
Special Populations
Preterm infants exposed to maternal magnesium therapy require adapted calcium and magnesium intakes based on postnatal blood concentrations, as they may have elevated magnesium levels and limited renal excretion capacity 1.
Growing premature infants have the highest calcium requirements (up to 140 mg/kg/day) to match fetal accretion rates of 3.4 mmol Ca/kg/day, which serves as the reference standard for optimal bone mineralization 1.
The adequacy of calcium and phosphorus provision can be assessed by monitoring urinary excretion - both should be excreted simultaneously with low urine concentrations (>1 mmol/L), indicating a slight surplus and adequate intake 1.